P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 193,777 shares at $470.15 ($51.2M) on 2017-08-18, disclosed to the SEC on 2017-08-18.
Open-market sale of $51.2M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 422 | $0 | 0.0% |
| 2 | $0.00 | 84,613 | $0 | 0.0% |
| 3 | $470.17 | 10,986 | $5.2M | 10.1% |
| 4 | $470.17 | 10,986 | $5.2M | 10.1% |
| 5 | $471.41 | 7,159 | $3.4M | 6.6% |
| 6 | $471.41 | 75,406 |
| $35.5M |
| 69.4% |
| 7 | $470.00 | 1,305 | $613K | 1.2% |
| 8 | $470.15 | 2,900 | $1.4M | 2.7% |
| Total | $264.37 avg | 193,777 | $51.2M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |